Eric Topol, M.D., Chief Academic Officer, Scripps Health
Eric Topol is a practicing cardiologist with Scripps Clinic and a pioneer in the field of cardiovascular medicine. Of special interest to Eric are genomics, wireless sensors, preventive cardiology (including heart attack prevention), coronary artery disease and preventive medicine. In a 2012 poll conducted by Modern Healthcare, Eric was voted as the number one Most Influential Physician Executive in the United States. An avid educator, he founded a medical school with the goal of training future generations of physician-scientists. In addition, he ran the Cleveland Clinic heart program for 14 years and brought it to the number one ranking by U.S. News and World Report for over 10 years consecutively. In 2009, Eric was selected as one of the country’s 12 “Rock Stars of Science” in GQ magazine. He was also elected to the Institute of Medicine of the National Academy of Sciences and is one of the top 10 most cited researchers in medicine.
Sonny Vu, Ph.D., Co-founder and CEO, Misfit Wearables
Sonny is the co-founder of Misfit Wearables, makers of wearable sensor products for wellness and medical applications. He is also the co-founder of AgaMatrix, which made the world’s first hardware medical device (a glucose meter) that works with the iPhone, winner of the Red Dot Design Award, and has sold over 1 billion biosensors for people with diabetes. Previously, he was CTO of a software start-up where he invented a number of machine learning-assisted natural language processing technologies.
Michael Weintraub, President and CEO, Humedica
Prior to launching Humedica, Michael served as Senior Managing Director at Leerink Swann. Previously, he was President and CEO of PHARMetrics, a health care informatics company, which was successfully sold to IMS Health in 2005. Michael has more than 30 years of experience in health care technology, information services and consulting. Michael serves as Chairman of the Board of Phreesia, a software company that develops automated patient check-in tools, and sits on the board of Anceta, the medical informatics subsidiary of the American Medical Group Association (AMGA). Michael is a member of the Board of Directors of JDRF New England Chapter – Bay State Branch. In 2010, Michael was selected to participate in 12×12, a Massachusetts initiative to multiply entrepreneurship by engaging the creativity and experience of 12 of the state’s leading CEO’s and 12 venture capitalists.
Frank Williams, CEO, Evolent Health
Frank is responsible for all aspects of Evolent Health’s strategic and operational management. He also serves as Vice Chairman of The Advisory Board, a best practices research and technology provider to the healthcare industry. During Frank’s tenure as Chairman and CEO, The Advisory Board grew to $1.8B+ in market capitalization and was ranked in the top 20 best run companies in North America by Forbes. Prior to joining The Advisory Board Company, Frank served as President of MedAmerica OnCall, President of Vivra Orthopedics and as a Management Consultant for Bain & Co. He currently serves on the boards of Privia Health and Head-Royce School.
Anne Wojcicki, Co-founder and CEO, 23andMe
Anne worked for 10 years overseeing healthcare investments at Investor AB and Passport Capital, focusing on biotechnology companies. In 2006, she left the investing world with the hope that she could have a positive impact on research and medicine, and she founded 23andMe with Linda Avey. Anne saw a need for creating a way to generate more personalized information, so that commercial and academic researchers could better understand and develop new drugs and diagnostics. Forbes named Anne to the list of Power Women 2013: Women to Watch This Year.
Julie Yoo, C0-founder and Chief Product Officer, Kyruus
Julie was previously the VP of Clinical Product Strategy at Generation Health where she oversaw the development of the company’s clinical programs and data analytics platform. Julie also led the Product Management efforts at Knome, the private arm of George Church’s Personal Genome Project, where she developed and launched a bioinformatics platform for conducting individualized genomic sequence analysis. Julie’s passion for data-driven businesses began as a software engineer at Endeca Technologies, where she ultimately helped to lead Endeca’s efforts in the health care industry as a Sales Engineer for Strategic Accounts.
Jack Young, Director, Qualcomm Life
Jack heads up the $100M Qualcomm Life Fund (QLF) at Qualcomm Ventures, which was recently ranked as one of the most prolific venture investors in the digital health sector. His investment interests are focused in the areas of intersection of healthcare products and services and digital/wireless technologies including. Jack’s QLF digital health investments include: Airstrip, AliveCor, ClearCare, Fitbit, goBalto and Telcare. Prior to Qualcomm, Jack was EVP and US Country Manager at ZTE who helped establish the company’s US market presence. He was a sales and marketing executive at Nokia following the acquisition of Amber Networks where he was founding AVP of marketing.
Jessica Zeaske, Ph.D., Vice President, Research & Development, Lemhi Ventures
Jessica began her career writing software for a start-up health care delivery company. She moved to a merchant bank, Greenspring Advisors, where she worked exclusively with companies in the health care services sector. She developed experience in licensing and intellectual property management as Start-up Manager at Oregon Health and Science University and as Associate Director and co-founder of the Venture Center at the University of Minnesota. Jessica is a past board member of OneHealth Solutions and currently serves on the board of PlanSource.
